Stifel Maintains Hold on Bio-Techne, Raises Price Target to $65
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Daniel Arias maintains Bio-Techne (NASDAQ:TECH) with a Hold and raises the price target from $60 to $65.
Stifel analyst Daniel Arias maintains Bio-Techne (NASDAQ:TECH) with a Hold and raises the price target from $60 to $65.